SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-20-000039
Filing Date
2020-05-11
Accepted
2020-05-11 08:12:05
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20200331.htm   iXBRL 10-Q 1574891
2 EX-31.1 eveloq12020exhibit311.htm EX-31.1 22108
3 EX-32.1 eveloq12020exhibit321.htm EX-32.1 12010
9 evlo-20200331_g1.jpg GRAPHIC 40026
  Complete submission text file 0001694665-20-000039.txt   5635161

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20200331.xsd EX-101.SCH 40660
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20200331_cal.xml EX-101.CAL 62666
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20200331_def.xml EX-101.DEF 156178
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20200331_lab.xml EX-101.LAB 507651
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20200331_pre.xml EX-101.PRE 294700
26 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20200331_htm.xml XML 698465
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 20862706
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences